Minimally Invasive Surgical Instruments Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Minimally Invasive Surgical Instruments Market Trends and Growth Drivers

Increasing Preference for MISs Drives Market

• There has been a paradigm shift in surgical procedures from conventional surgeries to minimally invasive surgeries.
• Minimally invasive surgeries are video-assisted and are more accurate.
• These surgeries involve less scarring and smaller incisions, retaining the organ’s original structure without deforming layers of its cellular.
• Moreover, carbon dioxide is used in minimally invasive surgery to enlarge the abdominal cavity to reduce blood loss during surgery.
• Moreover, less post-operative pain in minimally invasive surgeries contributes to the growing popularity of minimally invasive surgeries.
• As per studies, almost 55% of the heart valve replacements in Germany are done minimally invasively, while the number of Vietnam is around 50%.
• Further, there is a significant increase in the geriatric population, image perfection trend, and health awareness, globally.
• Moreover, the geriatric population is vulnerable to various chronic diseases, such as cardiovascular diseases, cancer, obesity, and arthritis.
• According to the population division of the Department of Economic and Social Affairs (DESA) in the United Nations Secretariat, aged people are expected to make up 30% of the population in China by 2050.
• The population of people aged 60 years and above is expected to reach 1.4 billion by 2030 and 2.1 billion by 2050, globally.
• Plastic and reconstructive surgeries, which are generally performed for cosmetic purposes, have also gained popularity.
• As per the American Society of Plastic Surgeons, 7% more minimally invasive cosmetic surgeries were performed in the U.S. in 2023 than in 2022.
• This is because the primary purpose of such procedures is enhancing the looks, and a nasty scar can nullify the entire procedure.

Emerging Economies Will Witness Lucrative Opportunities

• The growth of such instruments market is predicted to be catalyzed by opportunities in untapped and emerging markets with high potential due to improved healthcare infrastructure, unmet healthcare needs, rise in chronic diseases, and increase in demand for cost-effective and low recovery time surgeries.
• In addition, the healthcare industry in emerging economies is growing at a significant rate owing to augmentation in demand for better healthcare services, significant investments by governments to improve healthcare infrastructure, and growth of the medical tourism industry in such countries.
• The trend of medical tourism is increasing in emerging economies such as India, China, Thailand, Brazil, Malaysia, Mexico, and South Korea increasing the number of surgical procedures performed and offering high growth opportunities for minimally invasive surgical instruments.
• According to the report of Organisation for Economic Co-operation and Development (OECD), healthcare is costlier in developed countries.
• However, developing countries, such as India and Columbia are highly popular because of the high-quality care available at lower costs.
• The popularity of ambulatory surgery centers is rising owing to the burgeoning number of such centers, cost-effective treatment, high adoption rate of MIS procedures, rise in cosmetic procedures, and increasing trend of outpatient facilities.
• Moreover, rising surgical procedures in ambulatory settings due to the non-availability of beds & longer waiting times in hospitals and increase in acceptance of less complex minimally invasive surgery in ambulatory centers are expected to drive the category growth.

Minimally Invasive Surgical Instruments Market Analysis

Insights by Type

The handheld instruments category accounted for the largest revenue share, of 55%, in 2024, and it is expected to witness the highest CAGR during the prediction period. This is due to the increasing adoption of such instruments for various MIS surgeries, surging acceptance of robotic surgeries, and rising preference of surgeons for such instruments. Moreover, these instruments are cost-efficient, easy to operate, and majorly used across the globe, resulting in high sales in the category.

These types are covered:

• Handheld Instruments (Largest and Fastest-Growing Category)
  • Cutter instruments
    • Trocars
    • Rasps
    • Others
  • Visualizing scopes
  • Auxiliary instruments
    • Staplers
    • Closure devices
    • Cannulas
    • Clamps
  • Retractors
  • Dilators
  • Graspers
  • Sutures
  • Others
• Guiding Devices
  • Guiding catheters
  • Guidewires
• Inflation Systems
  • Balloon dilators and inflators
  • Insufflators and insufflator needles
• Electrosurgical Instruments
  • Electrosurgical instruments and accessories
  • Electrosurgical generators
  • Electrocautery devices

Insights by Application

Cardiovascular surgery accounted for the largest revenue share, and it is further expected to have the highest CAGR during the forecast period, of 10.5%. This can be ascribed to the fact that MIS procedures provide numerous advantages over conventional surgical procedures, such as reduced blood loss, shorter hospital stay as well as recovery time, and lower surgical trauma; rising number of cardiovascular procedures owing to the increase in CVDs; surging adoption of advanced technology to perform such surgeries, and escalating count of patients in hospitals.

Furthermore, the orthopedic surgery category will witness substantial growth during the predicted period. This is due to the skyrocketing incidence of orthopedic disorders, burgeoning elderly population, growing number of roads injuries, surging demand for devices that support an immediate cure, and increasing R&D spending by key players.

These applications are covered:

• Laparoscopy
• Cardiovascular (Largest and Fastest-Growing Category)
• Cosmetic Surgery
• Orthopedic Surgery
• Obstetrics and Gynecology
• Ophthalmology
• Neurosurgery
• Urology
• Others

Insights by End User

Hospitals accounted for the largest revenue share in 2024, of 55%, and they grow the fastest during the prediction period. This can be attributed to the high availability of skilled surgeons, high patient preference and satisfaction, operate complex surgical procedures, increase in awareness about the availability of innovative products, and need to upgrade their devices and services. Furthermore, minimally invasive surgeries are widely operated in hospitals as they can afford higher installation & maintenance costs of the complex minimally invasive surgical instruments.

These end users are covered:

• Hospitals (Largest and Fastest-Growing Category)
• Ambulatory Surgical Centers (ASCs)
• Research Institutes
• Others

Minimally Invasive Surgical Instruments Market Geographical Outlook

North America led the market with a revenue share of around 40% in 2024, and it is further expected to maintain its dominance during the forecast period. This can be attributed to the presence of well-established healthcare systems, increase in the prevalence of diseases, such as cardiac and orthopedic disorders, higher adoption rate for technologically advanced devices, and shifting preference towards outpatient surgeries.

Moreover, the U.S. contributes the majority of revenue to the North American market, owing to the surging burden of diseases requiring interventional procedures, rising awareness regarding minimally invasive surgical procedures, and growing health consciousness among individuals.

The APAC market will register the fastest growth in the market, with a CAGR of 12%, in the coming years. This is due to the rising cases of chronic diseases, growing elderly population, increasing awareness of consumers regarding medical device outsourcing, growing trend of medical tourism, and surge in healthcare expenditure. Furthermore, developing countries, such as China, India, and South Korea significantly contribute to the market. As per studies, over 1.4 million cancer cases were diagnosed in India in 2022, while the incidence in China stood at 341.75 per 100,000.

The growing geriatric population is also driving the growth of the market. The WHO estimates 28% of the Chinese population to be in the age group of 60 and above by 2040. Similarly, India will have 347 million people falling in this age group by 2050, compared to 153 million in 2023. Moreover, 37.5% of the Japanese and 39.4% of the South Korean population could be be in the age group of 65 and above by 2050.

The regions and countries analyzed for this report include:

• North America (Largest Regional Market)
  • U.S. (Larger Country Market)
  • Canada (Faster-Growing Country Market)
• Europe
  • Germany (Largest Country Market)
  • U.K.
  • France (Fastest-Growing Country Market)
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • Japan
  • India (Fastest-Growing Country Market)
  • South Korea
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest Country Market)
  • Mexico (Fastest-Growing Country Market)
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Fastest-Growing Country Market)
  • South Africa (Largest Country Market)
  • U.A.E.
  • Rest of MEA

Minimally Invasive Surgical Instruments Market Share

• The market is consolidated as surgical instruments are also technically complicated and financially taxing to develop, manufacture, trial, and get approved.
• Minimally invasive instruments, being even more specialized than conventional ones, make it almost impossible for local and emerging companies to hold any sway.
• Further, end users are hospitals, ASCs, and research centers, which only buy from well-known market players.
• The vendors also often provide comprehensive maintenance, refurbishing, and sterilization services, which further strengthens their position in the market.
• Moreover, in cases of non-compliance, only the larger companies are in any position to pay the hefty fines.

Minimally Invasive Surgical Instruments Market News

• In January 2025, E8 Inc. unveiled a line of minimally invasive tools to enhance the performance of neurosurgical access devices manufactured by numerous companies, under a partnership with the Jacobs Institute.
• In November 2024, Medtronic plc acquired Fortimedix Surgical, a Dutch manufacturer of instruments for minimally invasive, robotic, and endoscopic procedures.
• In October 2024, LivsMed launched the ArtiSential 5, a 5-mm wristed articulating laparoscope.
• In September 2023, Stryker Corporation launched PROstep MIS Lapidus, an internal fixation system for the treatment of bunions. It allows orthopedic surgeons to reduce the deformity in the hallux valgus and then, fuse the first metatarsal cuneiform joint.